Related Experiment Videos
Advances in the use of alemtuzumab in CLL
1Department of Haematology, Oncology, Rheumatology, and Infectious Diseases, University of Ulm, 89069 Ulm, Germany.
Clinical Advances in Hematology & Oncology : H&O
|March 7, 2008
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.
Clinical advances in hematology & oncology : H&O·2026
Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.
Clinical advances in hematology & oncology : H&O·2026
Molecular residual disease (MRD) testing: advancing clinical decision-making in breast cancer.
Clinical advances in hematology & oncology : H&O·2026
SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.
Journal of translational medicine·2026